To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC43TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
175 supporting clones for gene CCDC43 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ436652 large cell carcinoma, lung .a 1 to 617 36 to 658   tiling clone,   623/981
(63 %)
31 diff
(96.9 %id)
BC047776 Lung, large cell carcinoma .a 2 to 2062 1 to 2061 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 2061/2061
(100 %)
0 diff
(100 %id)
EL734586 mixed .a 12 to 625 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
TI_1948211486   .a 12 to 598 132 to 721       590/1403
(42 %)
20 diff
(98.6 %id)
TI_1948211760   .a 12 to 697 128 to 815 R169P N170K T171L N172Q V173C ...     688/1433
(48 %)
31 diff
(97.9 %id)
TI_1948211488   .a 110 to 697 712 to 121       592/1284
(46 %)
15 diff
(98.9 %id)
TI_1948211489   .a 147 to 697 687 to 129       557/1371
(40 %)
30 diff
(97.9 %id)
TI_1948211763   .a 325 to 697 497 to 125       373/397
(93 %)
0 diff
(100 %id)
NM_144609.2   .b 1 to 2143 1 to 2143 exact RefSeq,   2143/2147
(99 %)
5 diff
(99.8 %id)
BX493050   .b 12 to 542 1 to 531   tiling clone,   531/531
(100 %)
1 diff
(99.9 %id)
BG714527 brain, hypothalamus .b 13 to 690 1 to 677       677/691
(97 %)
8 diff
(98.9 %id)
DB488062.
matches multiple genes
hypothalamus .b 22 to 699 1 to 675     also hits gene C17orf104 675/675
(100 %)
19 diff
(97.2 %id)
BX488082   .b 25 to 603 1 to 577       577/577
(100 %)
7 diff
(98.8 %id)
BX473346   .b 25 to 767 1 to 740 R216G T217H Q218R R219E E221S ...     740/740
(100 %)
4 diff
(99.5 %id)
BG704214 brain, hippocampus .b 26 to 766 7 to 746 E211A E213G K214P K215P R216Q ...     740/749
(98 %)
14 diff
(98.2 %id)
DA885794   .b 29 to 484 2 to 457   capped   456/456
(100 %)
0 diff
(100 %id)
DN996797 breast cancer, Mammary gland (cancer tissue) .b 32 to 540 1 to 508       508/508
(100 %)
11 diff
(97.9 %id)
BP233670 coronary artery .b 33 to 613 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM012684 brain, neuroblastoma, cell line .b 33 to 615 1 to 594       594/750
(79 %)
21 diff
(97.2 %id)
DR157494 human embryonic stem cells differentiated toan early endodermal cell type .b 34 to 793 1 to 760 exact     760/760
(100 %)
0 diff
(100 %id)
TI_59381906   .b 34 to 615 103 to 695       593/749
(79 %)
20 diff
(97.4 %id)
BX501027 Liver .b 35 to 542 1 to 508       508/508
(100 %)
3 diff
(99.5 %id)
BI091945 cervix .b 35 to 650 1 to 618       618/618
(100 %)
5 diff
(99.2 %id)
BM803420 leiomyosarcoma, uterus .b 35 to 578 1 to 550       548/1102
(49 %)
22 diff
(98.1 %id)
BQ215412 large cell carcinoma, lung .b 35 to 855 1 to 827 exact     827/848
(97 %)
7 diff
(99.2 %id)
AK056357   .b 36 to 2117 1 to 2082 L174F available from FLJ,   2082/2082
(100 %)
1 diff
(100.0 %id)
BJ990408 hepatoblastoma .b 36 to 618 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BQ065825 lymph, lymphoma, cell line .b 36 to 974 14 to 959 exact     946/1036
(91 %)
39 diff
(96.3 %id)
BM843452 lymph node, stomach .b 36 to 606 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DA165936 amygdala .b 37 to 609 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA369831 subthalamic nucleus .b 37 to 587 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AL709972 human skeletal muscle .b 37 to 870 1 to 833 T139A L204P     833/844
(98 %)
9 diff
(99.0 %id)
DA705278   .b 37 to 497 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
CN373070 embryonic stem cells, cell lines H1, H7, andH9 .b 38 to 721 10 to 693 exact     684/693
(98 %)
6 diff
(99.2 %id)
BC023298 Lung, large cell carcinoma .b 40 to 2135 1 to 2096 exact tiling clone, available from MGC, AAA   2096/2096
(100 %)
0 diff
(100 %id)
BQ424333 leiomyosarcoma, uterus .b 41 to 698 1 to 671       671/772
(86 %)
19 diff
(97.6 %id)
BX404065 neuroblastoma .b 42 to 975 1 to 933 S5A E6K V7W A8P A11X ...     933/933
(100 %)
7 diff
(99.3 %id)
DB465378.
matches multiple genes
hippocampus .b 42 to 712 1 to 669     also hits gene C17orf104 669/669
(100 %)
15 diff
(97.8 %id)
BQ057675 lymph, lymphoma, cell line .b 43 to 916 1 to 879 A205P     879/989
(88 %)
24 diff
(97.6 %id)
BE514455 Burkitt lymphoma, lymph .b 44 to 648 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
CK822285 Pancreas, Purified pancreatic islet .b 47 to 596 9 to 558     Submitted on the opposite strand 550/558
(98 %)
6 diff
(99.0 %id)
BX443104 B cells (Ramos cell line) .b 52 to 1192 1 to 1131       1131/1131
(100 %)
23 diff
(98.0 %id)
BE409405 choriocarcinoma, placenta .b 53 to 671 12 to 631       620/631
(98 %)
6 diff
(99.1 %id)
BE784883 large cell carcinoma, lung .b 60 to 634 1 to 579   available from MGC,   579/579
(100 %)
5 diff
(99.2 %id)
CN373068 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 65 to 680 1 to 615   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 615/621
(99 %)
8 diff
(98.8 %id)
BI825078 pooled brain, lung, testis .b 68 to 916 27 to 892       866/893
(96 %)
43 diff
(95.2 %id)
TI_57202864   .b 68 to 916 27 to 892       866/893
(96 %)
43 diff
(95.2 %id)
BE408705 choriocarcinoma, placenta .b 72 to 673 1 to 602       602/602
(100 %)
0 diff
(100 %id)
CN373073 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 78 to 608 1 to 531       531/531
(100 %)
2 diff
(99.7 %id)
BM352137 Pancreas, Purified pancreatic islet .b 88 to 570 1 to 483       483/483
(100 %)
0 diff
(100 %id)
CN373069 embryonic stem cells, cell lines H1, H7, andH9 .b 88 to 636 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
CK822286 Pancreas, Purified pancreatic islet .b 93 to 671 579 to 1     Submitted on the opposite strand 579/579
(100 %)
4 diff
(99.4 %id)
CF551843 Pooled muscle (cardiac and skeletal) .b 94 to 928 1 to 837       837/837
(100 %)
3 diff
(99.7 %id)
CN373072 embryonic stem cells, cell lines H1, H7, andH9 .b 97 to 774 1 to 679       679/679
(100 %)
1 diff
(99.9 %id)
BM351826 Pancreas, Purified pancreatic islet .b 117 to 674 558 to 1       558/558
(100 %)
0 diff
(100 %id)
AA216130   .b 158 to 569 1 to 415       395/415
(95 %)
24 diff
(94.3 %id)
AI659121 Prostate .b 195 to 675 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AW074357 2 pooled high-grade transitional celltumors, genitourinary tract .b 224 to 675 452 to 1       452/452
(100 %)
2 diff
(99.6 %id)
BQ051161 leiomyosarcoma, uterus .b 237 to 1060 1 to 841       841/1025
(82 %)
19 diff
(98.2 %id)
DB555620 hypothalamus .b 247 to 675 1 to 429     Submitted on the opposite strand 429/429
(100 %)
2 diff
(99.6 %id)
AI674368 Prostate .b 278 to 675 400 to 1       400/400
(100 %)
4 diff
(99.0 %id)
AW175845 breast .b 283 to 500 1 to 219       219/219
(100 %)
7 diff
(96.9 %id)
BM049253 carcinoma, cell line, Prostate .b 358 to 869 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
BQ945564 carcinoma, cell line, Prostate .b 363 to 1304 1 to 944       944/949
(99 %)
21 diff
(97.8 %id)
BQ923039 carcinoma, cell line, Prostate .b 363 to 881 1 to 524       524/1436
(36 %)
13 diff
(99.1 %id)
AW207841   .b 372 to 697 14 to 337     Submitted on the opposite strand 324/353
(91 %)
5 diff
(98.6 %id)
BU502736 carcinoma, cell line, Prostate .b 381 to 901 17 to 542       526/1239
(42 %)
19 diff
(98.5 %id)
BG059147 nasopharynx, normal epithelium .b 423 to 690 1 to 267   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 267/276
(96 %)
4 diff
(98.6 %id)
BE646201 Prostate .b 426 to 675 250 to 1       250/250
(100 %)
0 diff
(100 %id)
BE925184 amnion_normal .b 473 to 916 22 to 466       445/466
(95 %)
12 diff
(97.5 %id)
BJ990409 hepatoblastoma .b 1525 to 2064 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB323952   .b 1579 to 2117 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BG706097 brain, hypothalamus .c 1 to 690 6 to 700 Q88* tiling clone,   695/701
(99 %)
15 diff
(97.9 %id)
NM_001099225.1   .c 5 to 2088 1 to 2084 exact RefSeq,   2084/2088
(99 %)
5 diff
(99.8 %id)
CB988532 Human Placenta, placenta .c 21 to 539 19 to 549 E6*     531/734
(72 %)
26 diff
(96.5 %id)
DB486610 hypothalamus .c 22 to 436 1 to 416       416/418
(99 %)
8 diff
(98.1 %id)
BX648868 human small intestine .c 23 to 2080 1 to 2058 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2058/2058
(100 %)
0 diff
(100 %id)
BX490435   .c 23 to 391 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
DB466861.
matches multiple genes
hippocampus .c 28 to 750 1 to 717 exact   also hits gene C17orf104 717/721
(99 %)
15 diff
(98.0 %id)
BM011775 brain, neuroblastoma, cell line .c 37 to 476 1 to 444       444/814
(54 %)
13 diff
(98.5 %id)
CN481360 eye .c 38 to 926 1 to 637       510/637
(80 %)
14 diff
(97.9 %id)
DA933398 Spleen .c 41 to 365 2 to 326   capped   325/325
(100 %)
0 diff
(100 %id)
AL833590 human endometrium .c 43 to 1958 1 to 1915 V91A available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1915/1915
(100 %)
5 diff
(99.8 %id)
CD675045 eye, lens .c 43 to 519 1 to 477 exact     477/477
(100 %)
0 diff
(100 %id)
BG179796 adenocarcinoma, cell line, Prostate .c 44 to 729 1 to 700 G18W G19R G20R G21R F22L ...     700/1182
(59 %)
22 diff
(98.2 %id)
TI_1948211487   .c 49 to 478 133 to 562       430/463
(92 %)
7 diff
(98.5 %id)
TI_1948211761   .c 49 to 440 134 to 525       392/420
(93 %)
10 diff
(97.7 %id)
BE393008 endometrium, adenocarcinoma cell line, uterus .c 63 to 724 1 to 665       665/665
(100 %)
16 diff
(97.6 %id)
BX492956   .c 93 to 703 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
DA449045 tongue, tumor tissue .d 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
BX474146   .d 4 to 511 1 to 508 A9T     508/508
(100 %)
2 diff
(99.7 %id)
DR422599 eye, Pterygium .d 16 to 713 1 to 698   tiling clone,   698/698
(100 %)
6 diff
(99.2 %id)
AI472155 pooled .d 260 to 721 479 to 18   AAA   462/462
(100 %)
0 diff
(100 %id)
AA909077 pooled .d 372 to 741 375 to 7   tiling clone,   369/375
(98 %)
0 diff
(100 %id)
BU182668 melanotic melanoma, skin .e 1 to 636 1 to 637 A2P tiling clone,   637/908
(70 %)
19 diff
(98.0 %id)
BU160478 melanotic melanoma, skin .e 1 to 669 1 to 679 A2P E22V A23G L24T V26S ... tiling clone,   679/943
(72 %)
22 diff
(97.7 %id)
BG215283   .e 263 to 826 1 to 564   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 564/564
(100 %)
2 diff
(99.7 %id)
BG202678   .e 572 to 826 271 to 18   AAA Submitted on the opposite strand 254/256
(99 %)
5 diff
(98.1 %id)
CN373071 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1 to 282 1 to 282 exact tiling clone, AAA   282/282
(100 %)
0 diff
(100 %id)
AI052740   .g-u 1 to 563 566 to 4   tiling clone,   563/566
(99 %)
0 diff
(100 %id)
AK098464 thyroid .g-u 416 to 1978 1 to 1554 exact available from FLJ,   1554/1554
(100 %)
11 diff
(99.3 %id)
BP269417 thyroid .g-u 418 to 1000 1 to 582 exact     582/582
(100 %)
5 diff
(99.2 %id)
BM474362 eye, retinoblastoma .g-u 422 to 1400 23 to 1005 exact tiling clone,   983/1033
(95 %)
6 diff
(99.5 %id)
BF795199 lymph, lymphoma, cell line .g-u 434 to 1201 5 to 759 I29M V30F Y31T M32W V33S ...     755/850
(88 %)
6 diff
(99.3 %id)
BI050068 placenta_normal .g-u 580 to 899 1 to 322 E66Q     322/322
(100 %)
7 diff
(97.9 %id)
BG110744 Bone, osteosarcoma, cell line .g-u 587 to 1284 1 to 699 exact     699/725
(96 %)
15 diff
(98.0 %id)
R18398 whole brain .g-u 616 to 993 1 to 385 exact     385/485
(79 %)
10 diff
(98.0 %id)
AW369992 breast .g-u 689 to 1246 1 to 556       556/556
(100 %)
15 diff
(97.4 %id)
AA356665   .g-u 693 to 977 1 to 285       285/285
(100 %)
0 diff
(100 %id)
AW964083   .g-u 694 to 1296 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
BF671791 muscle (skeletal) .g-u 787 to 1400 1 to 600       600/907
(66 %)
37 diff
(96.0 %id)
F12868 brain, total brain .g-u 822 to 1164 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
CB216692 normal endometrium, mid-secretory phase,cycle day 23, uterus .g-u 822 to 1448 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
R15365 whole brain .g-u 823 to 1270 1 to 464       464/465
(99 %)
18 diff
(96.2 %id)
BF842785 head_neck .g-u 835 to 1167 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BX431695 B cells (Ramos cell line) .g-u 847 to 1758 1 to 923       923/923
(100 %)
27 diff
(97.1 %id)
T75135 whole brain .g-u 851 to 1166 1 to 316       316/326
(96 %)
5 diff
(98.5 %id)
BG676504 skin, squamous cell carcinoma .g-u 910 to 1435 1 to 546       546/840
(65 %)
30 diff
(96.5 %id)
BM723129 eye, fetal eye .g-u 918 to 1447 1 to 530   fully sequenced,   530/530
(100 %)
0 diff
(100 %id)
AA279585 germinal center B cell .g-u 1014 to 1448 1 to 438       438/440
(99 %)
7 diff
(98.5 %id)
CB162942 Liver .g-u 1020 to 1602 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CN373074 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g-u 1096 to 1732 9 to 646       638/646
(98 %)
6 diff
(99.1 %id)
AA433999 ovarian tumor, ovary .g-u 1101 to 1507 7 to 413       407/415
(98 %)
6 diff
(98.6 %id)
BM453984 melanotic melanoma, skin .g-u 1162 to 1766 30 to 635   tiling clone, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 606/637
(95 %)
2 diff
(99.7 %id)
TI_149305228   .g-u 1162 to 1903 825 to 88   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 738/930
(79 %)
7 diff
(99.3 %id)
W07133 lung .g-u 1175 to 1548 1 to 387       387/394
(98 %)
19 diff
(95.2 %id)
BU685607 lung, Primary Lung Epithelial Cells .g-u 1218 to 1903 703 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 685/685
(100 %)
2 diff
(99.8 %id)
BX476329   .g-u 1234 to 1815 26 to 607       582/607
(95 %)
6 diff
(99.1 %id)
TI_149282936   .g-u 1254 to 2025 847 to 86   AAA   762/811
(93 %)
13 diff
(98.4 %id)
BQ775811 Bone, Human Chondrosarcoma Cell Line .g-u 1265 to 1999 753 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 735/735
(100 %)
1 diff
(99.9 %id)
AA366782 Pancreas .g-u 1267 to 1542 1 to 275       275/275
(100 %)
1 diff
(99.7 %id)
H19667 brain .g-u 1283 to 1712 1 to 438   fully sequenced,   438/438
(100 %)
9 diff
(98.0 %id)
AW438632 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g-u 1343 to 1769 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI687141 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g-u 1349 to 1769 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BQ185238 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g-u 1351 to 2025 693 to 19   AAA   675/675
(100 %)
0 diff
(100 %id)
AA504328 germinal center B cell .g-u 1369 to 1774 409 to 6       404/409
(98 %)
0 diff
(100 %id)
CF129680 Chondrosarcoma Lung Metastasis cell lines, lung .g-u 1381 to 1515 1 to 135       135/135
(100 %)
0 diff
(100 %id)
AI948491 2 pooled tumors (clear cell type), Kidney .g-u 1387 to 2025 645 to 8       638/645
(98 %)
0 diff
(100 %id)
AI034276 senescent fibroblast .g-u 1390 to 1769 395 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 380/380
(100 %)
2 diff
(99.5 %id)
BM677653 eye, fetal eye .g-u 1417 to 2025 627 to 19   fully sequenced, AAA   609/609
(100 %)
0 diff
(100 %id)
AI628938 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g-u 1424 to 1903 479 to 1       479/479
(100 %)
1 diff
(99.8 %id)
AW074675 colon, juvenile granulosa tumor .g-u 1446 to 1769 324 to 1       324/324
(100 %)
0 diff
(100 %id)
AA713664 germinal center B cell .g-u 1452 to 1774 326 to 6       321/326
(98 %)
0 diff
(100 %id)
BU679979 lung, Primary Lung Epithelial Cells .g-u 1454 to 2025 590 to 19   AAA   572/572
(100 %)
0 diff
(100 %id)
AW450917   .g-u 1455 to 2025 588 to 18   AAA   571/571
(100 %)
0 diff
(100 %id)
N31803 melanocyte .g-u 1456 to 1525 466 to 539       510/542
(94 %)
21 diff
(96.2 %id)
BI257636 cervical carcinoma cell line, cervix .g-u 1471 to 2021 51 to 608       558/637
(87 %)
19 diff
(97.1 %id)
BF932025 nervous_tumor .g-u 1488 to 1672 1 to 187       187/187
(100 %)
6 diff
(96.8 %id)
AI919535 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g-u 1488 to 1769 283 to 1       283/283
(100 %)
5 diff
(98.3 %id)
W58249 heart .g-u 1508 to 1838 1 to 330   fully sequenced, AAA   330/330
(100 %)
1 diff
(99.7 %id)
AW450396   .g-u 1513 to 2025 530 to 18   AAA   513/513
(100 %)
3 diff
(99.5 %id)
BE217772 carcinoid, lung .g-u 1517 to 2025 512 to 4       509/512
(99 %)
0 diff
(100 %id)
AA977064 pooled germ cell tumors .g-u 1518 to 1999 494 to 13   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 482/482
(100 %)
4 diff
(99.2 %id)
BE504863 pooled germ cell tumors .g-u 1519 to 1999 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI949813 2 pooled tumors (clear cell type), Kidney .g-u 1520 to 2025 512 to 7       506/512
(98 %)
0 diff
(100 %id)
AW466882 2 pooled tumors (clear cell type), Kidney .g-u 1526 to 2025 504 to 4       501/504
(99 %)
0 diff
(100 %id)
BF059575 pooled germ cell tumors .g-u 1530 to 2001 472 to 1       472/472
(100 %)
0 diff
(100 %id)
BQ002285 Chondrosarcoma, Left Pelvis .g-u 1530 to 2025 514 to 19   AAA   496/496
(100 %)
0 diff
(100 %id)
AA743584 germinal center B cell .g-u 1538 to 2026 508 to 22   AAA   487/487
(100 %)
2 diff
(99.6 %id)
AA814964 germinal center B cell .g-u 1547 to 2025 492 to 13   AAA   480/480
(100 %)
3 diff
(99.4 %id)
AI564121 Kidney .g-u 1555 to 2011 471 to 15       457/471
(97 %)
0 diff
(100 %id)
AI073854 pooled .g-u 1572 to 2028 466 to 10   tiling clone,   457/466
(98 %)
0 diff
(100 %id)
AI364994 pooled germ cell tumors .g-u 1598 to 1993 415 to 19   AAA   397/403
(98 %)
0 diff
(100 %id)
AW235144 pooled germ cell tumors .g-u 1604 to 2010 409 to 2       408/409
(99 %)
0 diff
(100 %id)
AW510570 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g-u 1611 to 2025 416 to 2       415/416
(99 %)
0 diff
(100 %id)
BQ002249 Chondrosarcoma, Left Pelvis .g-u 1618 to 2025 427 to 19   AAA   409/409
(100 %)
1 diff
(99.8 %id)
AW771224 Kidney .g-u 1631 to 2010 390 to 10       381/390
(97 %)
0 diff
(100 %id)
FN130249 breast carcinoma .g-u 1632 to 1743 1 to 112       112/113
(99 %)
3 diff
(97.4 %id)
AI769861 2 pooled tumors (clear cell type), Kidney .g-u 1635 to 2025 394 to 4       391/394
(99 %)
0 diff
(100 %id)
AW235541 Kidney .g-u 1649 to 2025 392 to 16   AAA   377/377
(100 %)
6 diff
(98.5 %id)
AW236106 Kidney .g-u 1654 to 2025 372 to 1       372/372
(100 %)
4 diff
(99.0 %id)
AI222131 pooled .g-u 1673 to 2025 363 to 11   AAA   353/353
(100 %)
2 diff
(99.5 %id)
H19668 brain .g-u 1682 to 2025 347 to 1   fully sequenced,   347/347
(100 %)
7 diff
(98.0 %id)
R38555 whole brain .g-u 1693 to 2025 355 to 18   AAA   338/339
(99 %)
5 diff
(98.6 %id)
R42461 whole brain .g-u 1694 to 2025 356 to 17   AAA   340/340
(100 %)
8 diff
(97.7 %id)
AI631614 pooled germ cell tumors .g-u 1702 to 1993 311 to 19   AAA   293/299
(97 %)
0 diff
(100 %id)
AA883261 parathyroid gland, parathyroid tumor .g-u 1723 to 2028 310 to 5       306/310
(98 %)
0 diff
(100 %id)
BF036304 adenocarcinoma, ovary .g-u 1728 to 2024 36 to 335       300/337
(89 %)
6 diff
(98.3 %id)
AI351534   .g-u 1735 to 2026 308 to 17   AAA   292/292
(100 %)
3 diff
(99.0 %id)
F10472 brain, total brain .g-u 1757 to 2025 269 to 1       269/269
(100 %)
1 diff
(99.7 %id)
W58250 heart .g-u 1808 to 2025 225 to 1   fully sequenced,   225/225
(100 %)
0 diff
(100 %id)
T25725   .g-u 1880 to 2025 143 to 1       143/143
(100 %)
2 diff
(98.7 %id)
W04844 lung Gene CCDC43, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C